Sirt3 restricts tumor initiation via promoting LONP1 deacetylation and K63 ubiquitination.
Liyi WuXinyi YanRuibo SunYe MaWanyu YaoBaogui GaoQingyuan ZhangJunxiong YouHao WangQinrui HanXue-Gang SunPublished in: Journal of translational medicine (2023)
Sirt3 represents a targetable metabolic checkpoint of oncogenesis, which produces energy restriction effects via maintaining LONP1 K145 deacetylation and subsequent K63 ubiquitination.